Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine

This publication has 17 references indexed in Scilit:

• Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana
  AIDS, 2006
• Development of Nevirapine Resistance in Infants Is Reduced by Use of Infant‐Only Single‐Dose Nevirapine plus Zidovudine Postexposure Prophylaxis for the Prevention of Mother‐to‐Child Transmission of HIV‐1
  The Journal of Infectious Diseases, 2006
• Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns
  AIDS, 2005
• Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose Nevirapine
  The Journal of Infectious Diseases, 2005
• Nevirapine (NVP) Resistance in Women with HIV‐1 Subtype C, Compared with Subtypes A and D, after the Administration of Single‐Dose NVP
  The Journal of Infectious Diseases, 2005
• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy
  New England Journal of Medicine, 2004
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
  The Lancet, 2003
• Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
  AIDS, 2001
• Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
  AIDS, 2000
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
  The Lancet, 1999